← Back to Search

Exercise Rehabilitation for Kidney Disease

N/A
Waitlist Available
Led By Clara J Bohm, MD, MPH
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at study baseline and 12 weeks after study start
Awards & highlights

Study Summary

This trial will test whether an exercise program can relieve symptoms and improve quality of life for people receiving chronic hemodialysis.

Eligible Conditions
  • End-Stage Kidney Disease
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at study baseline and 12 weeks after study start
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at study baseline and 12 weeks after study start for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in dialysis symptom burden at 12 weeks
Secondary outcome measures
Change in dialysis symptom burden at 26 and 52 weeks
Change in endurance/exercise capacity
Change in frailty status
+4 more
Other outcome measures
Change in physical activity behaviour pattern
Hospitalization rate
Mortality

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise RehabilitationExperimental Treatment1 Intervention
Participants will receive baseline exercise counselling as per Standard Care group. Participants will then participate in a 26-week exercise rehabilitation program incorporating 3 components: One-to-one self-management/resistance education once per week during the first 4 weeks of intervention. Participants will subsequently receive resistance training material to allow for home exercise for the remaining 22 weeks of the intervention. Intradialytic aerobic exercise on a cycle ergometer 3 times weekly for 26 weeks at their usual hemodialysis sessions. Four additional one-to-one standardized education sessions will be completed during the intervention period.
Group II: Standard CareActive Control1 Intervention
Participants will receive one exercise counseling session as part of their baseline assessment. Participants in the control group will not undergo any other exercise counseling or formal exercise intervention, but will not be prohibited from participating in exercise outside of the study protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Rehabilitation
2015
N/A
~180

Find a Location

Who is running the clinical trial?

The Wellness Institute at Seven Oaks General HospitalUNKNOWN
University of ManitobaLead Sponsor
592 Previous Clinical Trials
199,198 Total Patients Enrolled
Clara J Bohm, MD, MPHPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any vacancies for participants in this experiment?

"Per the information available on clinicaltrials.gov, this medical trial is not presently recruiting candidates. The study was initially made public in May 2015 and modified for the last time in October 2022. Although no longer enrolling patients, 587 other trials are actively seeking participants at present."

Answered by AI

What goals are the researchers hoping to achieve with this medical experiment?

"The primary purpose of this research project is to measure the alteration in symptom burden resulting from dialysis, which will be evaluated at baseline and 12 weeks after commencement. Secondary objectives involve assessing overall modified symptoms with the Dialysis Symptom Index as well as quality-of-life changes through self-reported EuroQol 5D-5L (EQ5D-5L) data collection and a Visual Analogue Scale, measured again at 26 and 52 weeks post study start."

Answered by AI
~17 spots leftby Mar 2025